Clinical characteristics of patients with COVID-19 depending on the treatment received and the presence of type 2 diabetes mellitus
BACKGROUND. Type 2 diabetes mellitus (T2DM) is an independent risk factor for adverse clinical outcomes in patients with Covid-19. There is currently insufficient data evaluating the efficacy and safety of drugs for the treatment of COVID-19, especially in patients with T2DM.AIM. The aim of study wa...
Saved in:
| Main Authors: | K. G. Lobanova, T. Y. Demidova, S. N. Perekhodov, M. B. Antsiferov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2021-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/12764 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
by: Tatiana Ivanovna Romantsova, et al.
Published: (2013-03-01) -
Efficacy of complex pathogenic therapy of diabetic distal neuropathy in patients with type 2 diabetes mellitus
by: Inessa I. Dubinina, et al.
Published: (2016-11-01) -
Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes
by: T. Yu. Demidova, et al.
Published: (2021-02-01) -
Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists
by: I. I. Dedov, et al.
Published: (2022-03-01) -
Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
by: Ivan Ivanovich Dedov, et al.
Published: (2011-03-01)